Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Weill Medical College of Cornell University
Weill Medical College of Cornell University
University of California, San Francisco
Icahn School of Medicine at Mount Sinai
PMV Pharmaceuticals, Inc
Tizona Therapeutics, Inc
Essen Biotech
IDEAYA Biosciences
University of Kentucky
Maastricht University Medical Center
Evopoint Biosciences Inc.
Portland VA Medical Center